Filing Details

Accession Number:
0001209191-18-041006
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-03 16:16:45
Reporting Period:
2018-06-29
Accepted Time:
2018-07-03 16:16:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1446372 M Paul Silva C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp & Corp Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-29 859 $96.87 16,946 No 4 M Direct
Common Stock Disposition 2018-06-29 859 $171.87 16,087 No 4 S Direct
Common Stock Acquisiton 2018-06-29 1,289 $91.05 17,376 No 4 M Direct
Common Stock Disposition 2018-06-29 1,289 $166.05 16,087 No 4 S Direct
Common Stock Acquisiton 2018-06-29 809 $86.52 16,896 No 4 M Direct
Common Stock Disposition 2018-06-29 809 $161.57 16,087 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-06-29 859 $0.00 859 $96.87
Common Stock Stock Option (Right to Buy) Disposition 2018-06-29 1,289 $0.00 1,289 $91.05
Common Stock Stock Option (Right to Buy) Disposition 2018-06-29 809 $0.00 809 $86.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
860 2024-07-14 No 4 M Direct
9,024 2026-02-01 No 4 M Direct
8,899 2027-02-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 169 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.
  2. The option vests in 16 quarterly installments from 07/15/2014.
  3. The option vests in 16 quarterly installments from 02/02/2016.
  4. The option vests in 16 quarterly installments from 02/03/2017.